Lauric Haber

1.3k total citations
8 papers, 391 citations indexed

About

Lauric Haber is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology. According to data from OpenAlex, Lauric Haber has authored 8 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Lauric Haber's work include Monoclonal and Polyclonal Antibodies Research (7 papers), CAR-T cell therapy research (5 papers) and Immunotherapy and Immune Responses (3 papers). Lauric Haber is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), CAR-T cell therapy research (5 papers) and Immunotherapy and Immune Responses (3 papers). Lauric Haber collaborates with scholars based in United States. Lauric Haber's co-authors include Germaine Fuh, Jenny Boström, Richard A. Lerner, Robert F. Kelley, Patrick Koenig, Arvind Rajpal, Roberto Crea, Ramesh R. Bhatt, Toshihiko Takeuchi and Chingwei V. Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Lauric Haber

7 papers receiving 361 citations

Peers

Countries citing papers authored by Lauric Haber

Since Specialization

Citations

This map shows the geographic impact of Lauric Haber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauric Haber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauric Haber more than expected).

Fields of papers citing papers by Lauric Haber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauric Haber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauric Haber. The network helps show where Lauric Haber may publish in the future.

Co-authorship network of co-authors of Lauric Haber

This figure shows the co-authorship network connecting the top 25 collaborators of Lauric Haber. A scholar is included among the top collaborators of Lauric Haber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauric Haber. Lauric Haber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Translational findings support regimen selection for first‐in‐human study of ubamatamab (MUC16 × CD3 bispecific antibody) in patients with recurrent ovarian cancer 2024 ·Clinical and Translational Science ·Min Zhu, (unknown), Alison Crawford, Jurriaan Brouwer‐Visser, Pamela Krueger, Lauric Haber, (unknown), Thomas S. Uldrick, (unknown), John D. Davis, Marc W. Retter	0
2	Translational findings for odronextamab: From preclinical research to a first‐in‐human study in patients with CD20+ B‐cell malignancies 2022 ·Clinical and Translational Science ·Min Zhu, Kara Olson, Jessica R. Kirshner, (unknown), Hong Yan, Lauric Haber, Craig Meagher, Dina M. Flink, Srikanth Ambati, John D. Davis, A. Thomas DiCioccio, Eric Smith, Marc W. Retter	11
3	A PSMA-Targeting CD3 Bispecific Antibody Induces Antitumor Responses that Are Enhanced by 4-1BB Costimulation 2020 ·Cancer Immunology Research ·Danica Chiu, Richard Tavaré, Lauric Haber, Olulanu H. Aina, Kristin Vazzana, Priyanka Ram, (unknown), Jennifer Finney, (unknown), Pamela Krueger, Jason T. Giurleo, Dangshe Ma, Eric Smith, Gavin Thurston, Jessica R. Kirshner, Alison Crawford	33
4	A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys 2015 ·Scientific Reports ·Eric Smith, Kara Olson, Lauric Haber, Bindu Varghese, Paurene Duramad, Andrew D. Tustian, A. Oyejide, Jessica R. Kirshner, (unknown), Jayanthi Menon, (unknown), Douglas MacDonald, Joel Kantrowitz, Nicholas Papadopoulos, Neil Stahl, George D. Yancopoulos, Gavin Thurston, Samuel Davis	122
5	A Novel CD20xCD3 Bispecific Fully Human Antibody Induces Potent Anti-Tumor Effects Against B Cell Lymphoma in Mice 2014 ·Blood ·Bindu Varghese, Jayanthi Menon, Luis Rodríguez, Lauric Haber, Kara Olson, Paurene Duramad, A. Oyejide, Eric Smith, Gavin Thurston, Jessica R. Kirshner	4
6	High Affinity Antigen Recognition of the Dual Specific Variants of Herceptin Is Entropy-Driven in Spite of Structural Plasticity 2011 ·PLoS ONE ·Jenny Boström, Lauric Haber, Patrick Koenig, Robert F. Kelley, Germaine Fuh	66
7	Improving Antibody Binding Affinity and Specificity for Therapeutic Development 2008 ·Methods in molecular biology ·Jenny Boström, Chingwei V. Lee, Lauric Haber, Germaine Fuh	42
8	A general method for greatly improving the affinity of antibodies by using combinatorial libraries 2005 ·Proceedings of the National Academy of Sciences ·Arvind Rajpal, (unknown), Lauric Haber, (unknown), (unknown), Ramesh R. Bhatt, Toshihiko Takeuchi, Richard A. Lerner, Roberto Crea	113

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact